British journal of anaesthesia
-
Randomized Controlled Trial Comparative Study Clinical Trial
IV compared with brachial plexus infusion of butorphanol for postoperative analgesia.
In a randomized, double-blind, controlled study, we have compared two groups of patients receiving either continuous systemic i.v. or continuous brachial plexus infusion of butorphanol for analgesia after operations on the upper extremities. Twenty-two patients undergoing elective upper extremity surgery were allocated randomly to one of two groups to receive either butorphanol i.v. and saline injected into the brachial plexus sheath (i.v. group) or butorphanol injected into the brachial plexus sheath and saline i.v. (brachial plexus group). After surgery on the upper extremity under continuous axillary brachial plexus block, each patient received a continuous infusion of butorphanol either i.v. or into the brachial plexus sheath at a dose of 83.3 micrograms h-1. ⋯ From 9 h until 24 h after operation, pain scores were significantly higher in the i.v. group than in the brachial plexus group. The VAS score 9 h after operation was 3.3 (SD 2.7) in the i.v. group and 0.6 (0.9) in the brachial plexus group (P < 0.01); 12 h after operation 2.7 (1.8) in the i.v. group and 0.6 (0.9) in the brachial plexus group (P < 0.01); 18 h after operation 1.7 (1.0) in the i.v. group and 0.7 (1.0) in the brachial plexus group (P < 0.05); and 24 h after operation 3.2 (2.4) in the i.v. group and 0.7 (1.2) in the brachial plexus group (P < 0.01). We conclude that continuous injection of butorphanol into the brachial plexus sheath provided superior analgesia compared with continuous i.v. injection.
-
Randomized Controlled Trial Clinical Trial
Uptake of halothane and isoflurane by mother and baby during caesarean section.
Twenty-three patients undergoing Caesarean section received either 0.5% halothane or 0.8% isoflurane to supplement nitrous oxide-oxygen anaesthesia. We studied the rate of uptake of the agents by the mother and fetus by measuring partial pressures in maternal arterial (Pa) and fetal umbilical venous (Puv) blood. Mean induction-delivery interval did not differ between the halothane (10.8 min) and isoflurane (11.7 min) groups. ⋯ We conclude that both halothane and isoflurane are suitable agents for general anaesthesia for Caesarean section. The rate of uptake of isoflurane by the mother during Caesarean section was more rapid than halothane. The rate of uptake by the fetus from the mother was the same for halothane and isoflurane, so that fetal partial pressure as a fraction of the inspired partial pressure was greater for isoflurane than halothane.
-
Randomized Controlled Trial Clinical Trial
Spread of subarachnoid hyperbaric amethocaine in pregnant women.
In order to examine how the gestational period influences the spread of spinal anaesthesia, we have measured the extent of spinal block produced by hyperbaric amethocaine 8 mg in 90 women. The patients were allocated to one of five groups according to the gestational period: non-pregnant group (n = 17), first trimester group (6-12 weeks, n = 14), second trimester group (13-24 weeks, n = 26), third trimester group (25-36 weeks, n = 15) and term group (37-41 weeks, n = 18). Maximum cephalad spread of analgesia was significantly higher in the second trimester (median T3 (range T9-C6)), third trimester (T3 (T4-C7)) and term groups (T2.5 (T4-C8)) than in the nonpregnant (T4 (T8-T2)) and first trimester groups (T4 (T11-C7)). We found that not only term pregnancy but also second and third trimester pregnancies enhanced the spread of spinal anaesthesia, and that first trimester pregnancy did not affect the spread of spinal anaesthesia.
-
We describe the use of thrombelastography in HELLP syndrome (Haemolysis, Elevated Liver Enzymes, Low Platelets). It differentiated between two possible causes of significant haemorrhage and revealed an accompanying underlying fibrinolysis. This allowed specific therapy to be directed at both abnormalities and, we believe, helped prevent this patient from undergoing radical surgery to curb blood loss.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Extradural ropivacaine and bupivacaine in hip surgery.
We studied 126 patients undergoing elective hip surgery; they received 20 ml of 0.5%, 0.75%, 1.0% ropivacaine or 0.5% bupivacaine extradurally in a double-blind design. Sensory block (pinprick), motor block (modified Bromage scale), quality of analgesia and neuromuscular block were assessed intermittently. Heart rate and arterial pressure were measured at regular intervals. ⋯ Duration and quality of analgesia and motor block increased with the concentration of ropivacaine. Ropivacaine 1.0% provided a longer duration of analgesia and motor block, more intense motor block and more patients with satisfactory analgesia than 0.5% bupivacaine. More patients treated with the higher concentrations of ropivacaine required treatment for hypotension and bradycardia.